MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
Consolidators: BioPharmaceuticals
Baxter International Inc. (NYSE:BAX) CCF/CIMIT
Organization & Developments: Baxter
Parents
Baxter International Inc. (NYSE:BAX) CCF/CIMIT
Children
*All Baxter technologies are related to the blood and circulatory system.
*Baxter Healthcare Corporation
*Baxter is a global leader in delivering critical therapies for life-threatening conditions.
*Baxter: Areas of Expertise
*DEVELOPS MEDICAL DEVICES AND PHARMACEUTICALS TO TREAT HEMOPHILIA, IMMUNE DISORDERS, INFECTIOUS DISEASES, KIDNEY DISEASE, Baxter International Inc. (NYSE:BAX):#5 Medical Devices, $12.6B (2009), CCF/CIMIT
2014: Baxter to Split Into 2 Health Care Companies
2015: 10. Baxter: 15.0% Profit Margin
2017: VA_J--BAXTER- EXALIS SOFTWARE SERVICE CONTRACT
2020: Baxter lands major DoD contract
2020: Healthcare on the Move: Baxter Could Come Out Of The Pandemic Stronger Than Ever
2022: Baxter International Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2022: Baxter International: Despite Weakening On The Bottom Line, Shares Look Attractive_seekingalpha.com
2023: Baxter bids adieu to $5B kidney care division with spinout plan
2023: Baxter to sell biopharma solutions unit for $4.25B to private equity
2023: Baxter to spin off renal care, acute therapies units
2023: Why Baxter Is One Of My #1 2023 Bets For Healthcare/Medtech_seekingalpha.com
2024: Baxter announces updated IV solutions production timeline
2024: Baxter International Inc. 2023 Q4 - Results - Earnings Call Presentation
2024: Baxter: Deleveraging At A Very Steep Price
2025: After tough year, Baxter looks for next CEO to drive growth
Jumps
*Key People: Baxter
Finance & Acquisitions: Baxter